beta

ACRX

AcelRx Pharmaceuticals Inc.

Acrx

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of therapies for the treatment of acute pain.

Market Cap: 103 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.acelrx.com

Shares Outstanding: 50.3 Million

Float: 49.1 Million

Dividend: 0.0 (0.0%)

Beta: 2.670856

Sector: Industrials

Industry: Conglomerates

Short Interest (Jan 12, 2018): 4.77 Million

Ethical Flags

Animal testing

Longest drawdown: 1610 trading days

From: 2013-07-22 To: 2019-10-18

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud